These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 7951512

  • 1. Changes in plasma atrial natriuretic peptide during hemodialysis: mechanism of elevated levels in patients with chronic renal failure.
    Takagi T, Nishikawa M, Inada M.
    Endocr J; 1993 Apr; 40(2):257-61. PubMed ID: 7951512
    [Abstract] [Full Text] [Related]

  • 2. Atrial natriuretic peptide (ANP) in patients with chronic renal failure on maintenance haemodialysis.
    de Châtel R, Makó J, Tóth M, Barna I, Lang RE.
    Int Urol Nephrol; 1991 Apr; 23(2):177-83. PubMed ID: 1830872
    [Abstract] [Full Text] [Related]

  • 3. Changes in brain natriuretic peptide and atrial natriuretic peptide plasma concentrations during hemodialysis in patients with chronic renal failure.
    Haug C, Metzele A, Steffgen J, Grünert A.
    Horm Metab Res; 1994 May; 26(5):246-9. PubMed ID: 8076909
    [Abstract] [Full Text] [Related]

  • 4. Increased brain natriuretic peptide and atrial natriuretic peptide plasma concentrations in dialysis-dependent chronic renal failure and in patients with elevated left ventricular filling pressure.
    Haug C, Metzele A, Steffgen J, Kochs M, Hombach V, Grünert A.
    Clin Investig; 1994 Jun; 72(6):430-4. PubMed ID: 7950153
    [Abstract] [Full Text] [Related]

  • 5. N-terminal fragments of the proatrial natriuretic peptide in patients before and after hemodialysis treatment.
    Franz M, Woloszczuk W, Hörl WH.
    Kidney Int; 2000 Jul; 58(1):374-83. PubMed ID: 10886584
    [Abstract] [Full Text] [Related]

  • 6. [Clinical relevance of the determination of plasma atrial natriuretic peptide in children with chronic renal failure].
    Rascher W, Bald M, Kröner F, Tulassay T, Müller-Wiefel DE.
    Z Kardiol; 1988 Jul; 77 Suppl 2():61-4. PubMed ID: 2970176
    [Abstract] [Full Text] [Related]

  • 7. Plasma concentrations of atrial natriuretic peptide, arginine vasopressin and hormones of the renin-angiotensin system in patients with end-stage renal disease.
    Elias AN, Vaziri ND, Pandian MR, Kaupke J.
    Int J Artif Organs; 1989 Mar; 12(3):153-8. PubMed ID: 2526100
    [Abstract] [Full Text] [Related]

  • 8. Atrial natriuretic peptide plasma levels during hemodialysis and hemofiltration in patients with end-stage renal disease.
    Groll J, Hagemann J, Röhrich B, Schaefer K.
    Int J Artif Organs; 1989 May; 12(5):284-8. PubMed ID: 2525530
    [Abstract] [Full Text] [Related]

  • 9. Plasma atrial natriuretic peptide during hemodialysis with or without fluid removal.
    Shiota J, Kubota M, Hamada C, Koide H.
    Nephron; 1990 May; 55(3):283-6. PubMed ID: 2142515
    [Abstract] [Full Text] [Related]

  • 10. Clinical significance of atrial natriuretic peptide in human blood.
    Yamaji T, Ishibashi M, Takaku F, Sato F, Kamoi K, Nakaoka H, Fujii J, Hasegawa K, Morii H.
    Jpn J Med; 1987 May; 26(2):207-11. PubMed ID: 2957532
    [Abstract] [Full Text] [Related]

  • 11. Plasma levels of atrial natriuretic peptide in patients with chronic renal failure.
    Hasegawa K, Matsushita Y, Inoue T, Morii H, Ishibashi M, Yamaji T.
    J Clin Endocrinol Metab; 1986 Oct; 63(4):819-22. PubMed ID: 2943754
    [Abstract] [Full Text] [Related]

  • 12. Endothelin and atrial natriuretic peptide in non-insulin-dependent diabetic versus nondiabetic patients on chronic hemodialysis.
    Schleiffer T, Nagel D, Franz H, Falk M, Valentiner I, Wildburg G, Stark M, Brass H.
    Ren Fail; 1994 Nov; 16(6):747-58. PubMed ID: 7899586
    [Abstract] [Full Text] [Related]

  • 13. Adsorption of natriuretic factors in uremia.
    Franz M, Woloszczuk W, Hörl WH.
    Semin Nephrol; 2001 May; 21(3):298-302. PubMed ID: 11320498
    [Abstract] [Full Text] [Related]

  • 14. Role of volume overload in dialysis-refractory hypertension.
    Fishbane S, Natke E, Maesaka JK.
    Am J Kidney Dis; 1996 Aug; 28(2):257-61. PubMed ID: 8768921
    [Abstract] [Full Text] [Related]

  • 15. Digitalislike immunoreactive substances and extracellular fluid volume status in chronic hemodialysis patients.
    Bisordi JE, Holt S.
    Am J Kidney Dis; 1989 May; 13(5):396-403. PubMed ID: 2541609
    [Abstract] [Full Text] [Related]

  • 16. Central blood volume, atrial natriuretic peptide and intermittent hemodialysis.
    Wallin CJ, Rossi P, Jacobson SH, Leksell LG.
    Scand J Urol Nephrol; 2004 May; 38(1):78-84. PubMed ID: 15204432
    [Abstract] [Full Text] [Related]

  • 17. Plasma atrial natriuretic peptide in patients with chronic renal failure.
    Chen JH, Tsai JH, Lai YH, Hwang SJ.
    J Formos Med Assoc; 1990 Aug; 89(8):645-50. PubMed ID: 1981224
    [Abstract] [Full Text] [Related]

  • 18. Comparative effects of haemodialysis and haemofiltration on plasma atrial natriuretic peptide.
    Raine AE, Bock A, Muller FB, Erne P, Bolli P, Brunner F, Buhler FR.
    Nephrol Dial Transplant; 1989 Aug; 4(3):222-7. PubMed ID: 2524680
    [Abstract] [Full Text] [Related]

  • 19. Atrial natriuretic peptide and volume changes in children.
    Tulassay T, Rascher W, Ganten D, Schärer K, Lang RE.
    Clin Exp Hypertens A; 1986 Aug; 8(4-5):695-701. PubMed ID: 2944674
    [Abstract] [Full Text] [Related]

  • 20. Atrial natriuretic peptide in plasma of volume-overloaded children with chronic renal failure.
    Rascher W, Tulassay T, Lang RE.
    Lancet; 1985 Aug 10; 2(8450):303-5. PubMed ID: 2862469
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.